Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • is007
    Junior Member
    • Oct 2015
    • 2

    htseq-count overlap modes

    Hi! I'm using htseq-count to count reads from my RNASeq experiment mapping to genes. I have an alignment file where all reads are mapped to the genome, and now I am just counting reads for each gene. It seems to work fine, but I'm trying to understand a specific detail about how it works. Basically, it has 3 overlap modes and I am using the 'union':



    This is the documentation: http://www-huber.embl.de/users/ander...doc/count.html

    I'm wondering if anyone knows to what extend does it count partially mapped reads (2nd row from the figure), i.e. by how much should the read overlap for it to be counted?

    The figure implies it counts partial overlaps too, but does not specify what exactly the minimum overlap needs to be. I'm not finding this information in the documentation.

    Thanks!
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    A one base overlap counts as an overlap.

    Comment

    • is007
      Junior Member
      • Oct 2015
      • 2

      #3
      Thanks, looks like you're right. I've come to the same conclusion just now inspecting their python source code. How's that meaningful?

      I guess if there's a very small overlap (extreme case: just overlap 'A' from 'ATG' at beginning) then it's likely overlapping multiple genes, hence it's classified as 'ambiguous' and not counted?

      Comment

      • fanli
        Senior Member
        • Jul 2014
        • 197

        #4
        Yes, but that depends on how dense the genes are in your genome, and how long your reads are

        Comment

        • dpryan
          Devon Ryan
          • Jul 2011
          • 3478

          #5
          Originally posted by is007 View Post
          Thanks, looks like you're right. I've come to the same conclusion just now inspecting their python source code. How's that meaningful?
          There's no real meaning there other than how sets are dealt with.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          37 views
          0 reactions
          Last Post SEQadmin2  
          Working...